Second-generation jak2 inhibitors for advanced prostate cancer: Are we ready for clinical development? Cancers October-2 2021;13(20)
Date
10/01/2021
DOI
10.3390/cancers13205204Scopus ID
2-s2.0-85117018634 (requires institutional sign-in at Scopus site)
23 CitationsAuthor List
Beinhoff P, Sabharwal L, Udhane V, Maranto C, Laviolette PS, Jacobsohn KM, Tsai S, Iczkowski KA, Wang L, Hall WA, Dehm SM, Kilari D, Nevalainen MT
Author
William Adrian Hall MD Chair, Professor in the Radiation Oncology department at Medical College of Wisconsin